Intellia Therapeutics (NTLA) PT Lowered to $54 at Canaccord Genuity
Tweet Send to a Friend
(Updated - June 3, 2025 6:58 AM EDT)
Canaccord Genuity analyst Whitney Ijem lowered the price target on Intellia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Whitney Ijem lowered the price target on Intellia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
